Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002538344 | SCV003704425 | uncertain significance | Inborn genetic diseases | 2022-11-07 | criteria provided, single submitter | clinical testing | The c.5582C>T (p.P1861L) alteration is located in exon 10 (coding exon 10) of the WDR81 gene. This alteration results from a C to T substitution at nucleotide position 5582, causing the proline (P) at amino acid position 1861 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Ce |
RCV003311901 | SCV004010543 | uncertain significance | not provided | 2023-04-01 | criteria provided, single submitter | clinical testing | |
Genome |
RCV000845093 | SCV000986944 | not provided | Cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 2 | no assertion provided | phenotyping only | Variant interpretted as Uncertain significance and reported on 07/26/2017 by GTR ID 500031. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. |